TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test
At DNA Labs UAE, we offer the TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test. This test is designed to diagnose individuals with hearing loss and identify mutations or variations in the TECTA gene that may be responsible for the condition.
Test Details
TECTA gene deafness, autosomal dominant type 12 is a type of genetic deafness caused by mutations in the TECTA gene. The TECTA gene provides instructions for making a protein called alpha-tectorin, which is essential for the normal functioning of the inner ear.
NGS (Next-Generation Sequencing) genetic testing is used in this test. It is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of TECTA gene deafness, autosomal dominant type 12, NGS genetic testing can identify mutations or variations in the TECTA gene that may be responsible for the hearing loss.
Our test is conducted using NGS Technology, and the results are delivered within 3 to 4 weeks. The cost of the test is 4400.0 AED.
Sample Condition
We accept blood or extracted DNA samples for this test. Alternatively, you can provide one drop of blood on an FTA Card.
Doctor and Test Department
This test is performed by an ENT Doctor in our Genetics Test Department.
Pre Test Information
Prior to the test, we require the clinical history of the patient who is going for the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. We also recommend a Genetic Counselling session to draw a pedigree chart of family members affected with the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS3.
Importance of Genetic Testing
It is crucial to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing can provide valuable information for individuals and families affected by TECTA gene deafness, autosomal dominant type 12, including accurate diagnosis, prognosis, and potential treatment options.
At DNA Labs UAE, we prioritize the well-being of our patients and ensure that our testing services are conducted with the utmost care and accuracy.
Test Name | TECTA Gene Deafness autosomal dominant type 12 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS3 |
Test Details |
TECTA gene deafness, autosomal dominant type 12 is a type of genetic deafness caused by mutations in the TECTA gene. The TECTA gene provides instructions for making a protein called alpha-tectorin, which is essential for the normal functioning of the inner ear. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of TECTA gene deafness, autosomal dominant type 12, NGS genetic testing can be used to identify mutations or variations in the TECTA gene that may be responsible for the hearing loss. NGS genetic testing for TECTA gene deafness, autosomal dominant type 12 can help in the diagnosis of individuals with hearing loss and can also be used for carrier testing and prenatal testing in families with a known TECTA gene mutation. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing can provide valuable information for individuals and families affected by TECTA gene deafness, autosomal dominant type 12, including accurate diagnosis, prognosis, and potential treatment options. |